[go: up one dir, main page]

AU2001229340A1 - Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer - Google Patents

Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

Info

Publication number
AU2001229340A1
AU2001229340A1 AU2001229340A AU2934001A AU2001229340A1 AU 2001229340 A1 AU2001229340 A1 AU 2001229340A1 AU 2001229340 A AU2001229340 A AU 2001229340A AU 2934001 A AU2934001 A AU 2934001A AU 2001229340 A1 AU2001229340 A1 AU 2001229340A1
Authority
AU
Australia
Prior art keywords
kits
assessment
therapy
prevention
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229340A
Inventor
James Lillie
Kathleen Steinmann
Youzhen Wang
Yongyao Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
MILLENNIUM PREDICTIVE MEDICINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MILLENNIUM PREDICTIVE MEDICINE filed Critical MILLENNIUM PREDICTIVE MEDICINE
Publication of AU2001229340A1 publication Critical patent/AU2001229340A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001229340A 2000-01-14 2001-01-10 Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer Abandoned AU2001229340A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US17607700P 2000-01-14 2000-01-14
US60/176,077 2000-01-14
US18916700P 2000-03-14 2000-03-14
US60/189,167 2000-03-14
US19209900P 2000-03-24 2000-03-24
US60/192,099 2000-03-24
US19348000P 2000-03-29 2000-03-29
US60/193,480 2000-03-29
US20523000P 2000-05-15 2000-05-15
US60/205,230 2000-05-15
US21131500P 2000-06-09 2000-06-09
US60/211,315 2000-06-09
US22053400P 2000-07-25 2000-07-25
US60/220,534 2000-07-25
PCT/US2001/000798 WO2001051628A2 (en) 2000-01-14 2001-01-10 Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

Publications (1)

Publication Number Publication Date
AU2001229340A1 true AU2001229340A1 (en) 2001-07-24

Family

ID=27569146

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229340A Abandoned AU2001229340A1 (en) 2000-01-14 2001-01-10 Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

Country Status (2)

Country Link
AU (1) AU2001229340A1 (en)
WO (1) WO2001051628A2 (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6844325B2 (en) 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6746846B1 (en) 1999-06-30 2004-06-08 Corixa Corporation Methods for diagnosing lung cancer
US6858204B2 (en) 1999-06-30 2005-02-22 Corxia Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030125245A1 (en) 1999-06-30 2003-07-03 Tongtong Wang Compositions and methods for therapy and diagnosis of lung cancer
EP1637541B1 (en) * 1999-09-01 2010-03-03 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20020107381A1 (en) * 2000-09-29 2002-08-08 Friddle Carl Johan Novel human proteases and polynucleotides encoding the same
WO2001040269A2 (en) 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
EP1250434B1 (en) 2000-01-26 2008-04-16 Agensys, Inc. 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
EP1276867B1 (en) * 2000-03-22 2006-08-23 Bayer HealthCare AG Use of human latrophilin-like G protein-coupled receptor in screening methods
US20020164769A1 (en) * 2000-10-05 2002-11-07 Curtis Rory A.J. 32144, a novel human fatty acid amide hydrolase family member and uses thereof
AU2001275944A1 (en) * 2000-07-14 2002-01-30 Millennium Pharmaceuticals, Inc. 62088, a human nucleoside phosphatase family member and uses thereof
WO2002016593A2 (en) 2000-08-22 2002-02-28 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
WO2002016568A2 (en) * 2000-08-24 2002-02-28 Millenium Pharmaceuticals, Inc. 46863, a human methyltransferase and uses thereof
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
AU2002318112B2 (en) 2001-04-10 2007-12-06 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US20040003418A1 (en) 2001-04-10 2004-01-01 Aya Jakobovits Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
EP1385962A2 (en) * 2001-05-02 2004-02-04 Bayer HealthCare AG Human prolyl 4-hydroxylases
DK1410011T3 (en) 2001-06-18 2011-07-18 Netherlands Cancer Inst Diagnosis and prognosis of breast cancer patients
US7171311B2 (en) 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
JP2003250550A (en) * 2002-02-25 2003-09-09 Nissui Pharm Co Ltd Fat cell differentiation-related gene and protein
DE10211088A1 (en) * 2002-03-13 2003-09-25 Ugur Sahin Gene products differentially expressed in tumors and their use
US20040019915A1 (en) 2002-04-01 2004-01-29 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
AU2003255459A1 (en) * 2002-08-19 2004-03-11 Bayer Healthcare Ag Regulation of human secretin-type gpcr (latrophilin)
TW200418988A (en) 2002-09-30 2004-10-01 Oncotherapy Science Inc Method for diagnosing prostate cancer
ATE528397T1 (en) 2003-08-08 2011-10-15 Perseus Proteomics Inc GENE OVEREXPRESSED IN CANCER
ES2303390B1 (en) * 2003-09-24 2009-08-17 Progenika Biopharma, S.A. METHODS FOR IN VITRO AND IN VITRO DIAGNOSIS OF THE DUCTAL PANCREAS ADENOCARCINOMA AND / OR OF A PANCREATITIS; AND FOR THE DEVELOPMENT OF PHARMACS AGAINST DUCTAL PANCREAS ADENOCARCINOMA AND / OR AGAINST A PANCREATITIS.
JP4705026B2 (en) * 2004-03-19 2011-06-22 ジェノミディア株式会社 Vascular endothelial growth promoting gene
NZ556158A (en) * 2004-12-22 2010-04-30 Auckland Uniservices Ltd Trefoil factors and methods of treating proliferation disorders using same
US8535914B2 (en) * 2005-01-21 2013-09-17 Canon Kabushiki Kaisha Probe, probe set and information acquisition method using the same
FR2892730A1 (en) * 2005-10-28 2007-05-04 Biomerieux Sa Detecting the presence/risk of cancer development in a mammal, comprises detecting the presence/absence or (relative) quantity e.g. of nucleic acids and/or polypeptides coded by the nucleic acids, which indicates the presence/risk
JP2007267692A (en) * 2006-03-31 2007-10-18 Sysmex Corp Metastasis marker for lymph node and primer for breast cancer and method for judging lymph node metastasis of breast cancer using the same marker
KR102166408B1 (en) 2010-09-29 2020-10-16 어젠시스 인코포레이티드 Antibody drug conjugates (adc) that bind to 191p4d12 proteins
US10829772B2 (en) 2012-06-22 2020-11-10 Monsanto Technology Llc Unique modular vector design
CA2882745C (en) 2012-08-23 2022-03-29 Agensys, Inc. Antibody drug conjugates (adc) that bind to 158p1d7 proteins
WO2020117373A1 (en) 2018-12-03 2020-06-11 Agensys, Inc. Pharmaceutical compositions comprising anti-191p4d12 antibody drug conjugates and methods of use thereof

Also Published As

Publication number Publication date
WO2001051628A9 (en) 2003-07-17
WO2001051628A2 (en) 2001-07-19
WO2001051628A3 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2001229340A1 (en) Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2001241541A1 (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
AU2002322280A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2002337657A1 (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
AU2074201A (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
AU4592601A (en) Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
AU2002324451A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
AU2001236519A1 (en) Identification, assessment, prevention, and therapy of prostate cancer
AU2001251613A1 (en) Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU7994200A (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2003226676A1 (en) Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
AU7701100A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001245295A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
AUPQ923100A0 (en) Treatment of prostate cancer
AU2001268467A1 (en) Identification of genes and compounds for treatment of cancer
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2596901A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2074101A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
AU2002241720A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
AU2001238493A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers